相关实验视频
Updated: Jan 8, 2026

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice
Published on: August 23, 2019
RAS突变对乳头甲状腺癌的预后影响:系统性审查和元分析
Alireza Abdollahi1, Seyed Morteza Pourfaraji2, Fatemeh Ojaghi Shirmard2
1Department of Pathology, School of Medicine, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Qarib Street, Keshavarz Blvd., Tehran, Iran.
在20%的乳头甲状腺癌病例中发现了RAS突变,并且与更高的远程转移风险有关. 然而,这些突变不会显著影响其他临床结果,如复发或死亡率.
科学领域:
- 在瘤学瘤学.
- 遗传学 遗传学 是一个
- 分子生物学分子生物学
背景情况:
- 乳头甲状腺癌 (PTC) 是最常见的甲状腺癌.
- 激活RAS基因家族中的突变与PTC发育和行为有关.
研究的目的:
- 评估RAS基因突变与PTC患者的临床结果之间的关联.
- 确定PTC中RAS突变的流行率及其与转移,复发,死亡率和瘤大小的相关性.
主要方法:
- 一个系统的文献综述和对22项涉及4727名患者的研究的元分析.
- 数据提取包括RAS突变流行率和临床终点,如无复发生存率,死亡率,远程转移和瘤大小.
- 统计分析使用危险比率,赔率比率和平均差异来评估影响大小.
主要成果:
- 在PTC中RAS突变的综合流行率为20%.
- RAS突变与更高的远程转移风险显著相关 (OR = 3.12).
- 没有发现RAS突变与无复发生存率,整体死亡率,瘤复发或瘤大小之间的显著关联.
结论:
- RAS突变在20%的PTC病例中普遍存在,是远程转移的危险因素.
- RAS突变状态与其他临床结果没有显著相关.
- 拉斯突变检测可以帮助术后风险分层 PTC 患者,指导监测和治疗策略.
更多相关视频
04:01Transoral Robotic Total Thyroidectomy and Bilateral Central Regional Lymph Node Dissection for Papillary Thyroid Carcinoma
Published on: September 15, 2023
06:08Establishment and Characterization of Patient-Derived Xenograft Models of Anaplastic Thyroid Carcinoma and Head and Neck Squamous Cell Carcinoma
Published on: June 2, 2023
相关概念视频
The Ras Gene
Ras is a...
Abnormal Proliferation
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Small GTPases - Ras and Rho
Three regulatory proteins control their activity:
Cancer Survival Analysis